Public Profile

Hifibio, Inc.

Hifibio, Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates across various regions, focusing on innovative solutions in life sciences. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced biopharmaceuticals and diagnostic tools, achieving significant milestones in research and product launches. Hifibio's core offerings include cutting-edge antibody discovery platforms and next-generation sequencing technologies, which are distinguished by their precision and efficiency. The company’s commitment to quality and innovation has positioned it favourably within the competitive biotech landscape, earning recognition for its contributions to personalised medicine and therapeutic advancements. With a strong emphasis on research and development, Hifibio continues to push the boundaries of science, making a lasting impact on healthcare.

DitchCarbon Score

How does Hifibio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Hifibio, Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Hifibio, Inc.'s reported carbon emissions

Hifibio, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the industry. As such, Hifibio's climate commitments and strategies remain unspecified, highlighting a potential area for future development in sustainability practices.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hifibio, Inc.'s primary industry is , which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hifibio, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hifibio, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ligand Pharmaceuticals Incorporated

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Twist Bioscience Corporation

US
Health and social work services (85)
Updated 2 days ago

Sphere Fluidics Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

AbCellera

CA
Education services (80)
Updated 2 days ago

Bruker Cellular Analysis, Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers